These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7387143)

  • 1. In vitro and in vivo antibacterial activity of AB206, a new naphthyridine derivative.
    Nagate T; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):203-8. PubMed ID: 7387143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of a new nalidixic acid derivative, AB206.
    Nagate T; Komatsu T; Izawa A; Ohmura S; Namiki S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 May; 17(5):763-9. PubMed ID: 6156644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of miloxacin.
    Izawa A; Kisaki Y; Irie K; Eda Y; Nakagome T; Komatsu T
    Antimicrob Agents Chemother; 1980 Jul; 18(1):37-40. PubMed ID: 7416749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
    Ito A; Hirai K; Inoue M; Koga H; Suzue S; Irikura T; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):103-8. PubMed ID: 6446258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy on the biliary tract infections. XIII. Miloxacin, a novel chemotherapeutic agent, its excretion into bile and clinical effect on the biliary tract infections (author's transl)].
    Jpn J Antibiot; 1981 Sep; 34(9):1335-52. PubMed ID: 7328756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activity of DL-8280, a new oxazine derivative.
    Sato K; Matsuura Y; Inoue M; Une T; Osada Y; Ogawa H; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):548-53. PubMed ID: 6960805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound 64716, a new synthetic antibacterial agent.
    Wick WE; Preston DA; White WA; Gordee RS
    Antimicrob Agents Chemother; 1973 Oct; 4(4):415-20. PubMed ID: 4791302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.
    Nakamura S; Minami A; Katae H; Inoue S; Yamagishi J; Takase Y; Shimizu M
    Antimicrob Agents Chemother; 1983 May; 23(5):641-8. PubMed ID: 6575721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
    Tsuchiya K; Kida M; Kondo M; Ono H; Takeuchi M; Nishi T
    Antimicrob Agents Chemother; 1978 Oct; 14(4):557-68. PubMed ID: 718154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activity of AT-2266.
    Kouno K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1983 Jul; 24(1):78-84. PubMed ID: 6226242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
    Mitsukude M; Inoue M; Mitsuhashi S
    Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
    de Rautlin de la Roy Y; Toma V; Bobin B
    Curr Med Res Opin; 1978; 5(9):743-8. PubMed ID: 738079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.
    Otani T; Tanaka M; Ito E; Kurosaka Y; Murakami Y; Onodera K; Akasaka T; Sato K
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3750-9. PubMed ID: 14638477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.
    Sedlock DM; Dobson RA; Deuel DM; Lesher GY; Rake JB
    Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.
    Mine Y; Kamimura T; Nonoyama S; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1980 Jan; 33(1):36-43. PubMed ID: 7372548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
    Greenwood D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Wakai Y; Kamimura T; Tawara S; Matsumoto S; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):88-98. PubMed ID: 8436563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.